Systolic time intervals (STI) do not reliably indicate optimal dosing for cardioactive glycosides like digitoxin and digoxin after myocardial infarction. Individualized therapy adjustments based on STI changes are not supported by this study.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: